(Q61774659)

English

A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis

scientific article published on 06 March 2012

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit